Effects of Acupuncture on Symptoms of Stable Angina
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Mar 7, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether acupuncture can help reduce pain for people with stable angina, which is a type of chest pain that happens when the heart doesn't get enough blood. The researchers want to see if a specific 12-point acupuncture treatment can lessen the symptoms and improve the quality of life for patients. The study will include both men and women aged 21 and older who have been diagnosed with stable angina and have been experiencing symptoms at least once a week for the past month.
Participants in the trial will either receive acupuncture treatments twice a week for five weeks or take part in a control group where they will watch educational talks instead of receiving acupuncture. The goal is to find out if acupuncture can help reduce pain and improve overall health for those living with angina. It’s important to note that pregnant women and those with certain health conditions may not be eligible to participate. If you’re interested in finding out more or seeing if you qualify, it’s a great opportunity to explore a potential new way to manage angina symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of stable angina or chest pain syndrome for at least 1 month (pain, pressure, or discomfort in the chest or other areas of the upper body)
- • Treated with medical therapy for at least 1 month
- • Experiencing symptoms at least once per week
- • Speak and read English
- • 21 years of age minimum
- Exclusion Criteria:
- • Pregnancy as some acupuncture points included in the protocol are contraindicated in pregnancy
- • Physical or cognitive limitations that will prevent informed consent or completion of study tasks
- • Use of steroid or prescription analgesic medications
- • Concomitant biofeedback, professional massage and acupuncture.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Holli A. DeVon, PhD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported